PhRMA: now marketing limits are necessary; but critics unappeased

20 July 2008

The decision by the Pharmaceutical Research and Manufacturers of America (PhRMA) to change its ethics rules (see page 13) has been backed up with messages of support from the major drugmakers, but it has not silenced critics who are already calling for more concessions from the sector. One pharmaceutical industry sympathizer also ridiculed the move by the PhRMA to ban pens and coffee mugs carrying a firm or product name and logo. "Silly and trivial as this sounds," Peter Pitts, the president of the Center for Medicine in the Public Interest wrote on his drugwonks.com blog, "the more serious issue at play is the caving in by the pharmaceutical industry to misguided political pressure."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight